These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25362845)

  • 1. Electron paramagnetic resonance: a powerful tool to support magnetic resonance imaging research.
    Danhier P; Gallez B
    Contrast Media Mol Imaging; 2015; 10(4):266-81. PubMed ID: 25362845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of paramagnetic melanin on the MRI contrast in melanoma: a combined high-field (11.7 T) MRI and EPR study.
    Godechal Q; Mignion L; Karroum O; Magat J; Danhier P; Morandini R; Ghanem GE; Leveque P; Gallez B
    Contrast Media Mol Imaging; 2014; 9(2):154-60. PubMed ID: 24523060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo visualization and ex vivo quantification of murine breast cancer cells in the mouse brain using MRI cell tracking and electron paramagnetic resonance.
    Danhier P; Magat J; Levêque P; De Preter G; Porporato PE; Bouzin C; Jordan BF; Demeur G; Haufroid V; Feron O; Sonveaux P; Gallez B
    NMR Biomed; 2015 Mar; 28(3):367-75. PubMed ID: 25611487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal cell tracking of a spontaneous metastasis model: comparison between MRI, electron paramagnetic resonance and bioluminescence.
    Danhier P; De Preter G; Magat J; Godechal Q; Porporato PE; Jordan BF; Feron O; Sonveaux P; Gallez B
    Contrast Media Mol Imaging; 2014; 9(2):143-53. PubMed ID: 24523059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI.
    Hyodo F; Murugesan R; Matsumoto K; Hyodo E; Subramanian S; Mitchell JB; Krishna MC
    J Magn Reson; 2008 Jan; 190(1):105-12. PubMed ID: 18006345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of redox status in a brain-disease mouse model by three-dimensional EPR imaging.
    Fujii H; Sato-Akaba H; Kawanishi K; Hirata H
    Magn Reson Med; 2011 Jan; 65(1):295-303. PubMed ID: 20860000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies with EPR and MRI on the in vivo tissue redox status estimation using redox-sensitive nitroxyl probes: influence of the choice of the region of interest.
    Matsumoto KI; Mitchell JB; Krishna MC
    Free Radic Res; 2018 Feb; 52(2):248-255. PubMed ID: 29320888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain imaging in methamphetamine-treated mice using a nitroxide contrast agent for EPR imaging of the redox status and a gadolinium contrast agent for MRI observation of blood-brain barrier function.
    Emoto MC; Yamato M; Sato-Akaba H; Yamada K; Matsuoka Y; Fujii HG
    Free Radic Res; 2015; 49(8):1038-47. PubMed ID: 25968953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroxyl Modified Tobacco Mosaic Virus as a Metal-Free High-Relaxivity MRI and EPR Active Superoxide Sensor.
    Dharmarwardana M; Martins AF; Chen Z; Palacios PM; Nowak CM; Welch RP; Li S; Luzuriaga MA; Bleris L; Pierce BS; Sherry AD; Gassensmith JJ
    Mol Pharm; 2018 Aug; 15(8):2973-2983. PubMed ID: 29771534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging.
    Yamada KI; Kuppusamy P; English S; Yoo J; Irie A; Subramanian S; Mitchell JB; Krishna MC
    Acta Radiol; 2002 Jul; 43(4):433-40. PubMed ID: 12225490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitroxyl Radical as a Theranostic Contrast Agent in Magnetic Resonance Redox Imaging.
    Matsumoto KI; Nakanishi I; Zhelev Z; Bakalova R; Aoki I
    Antioxid Redox Signal; 2022 Jan; 36(1-3):95-121. PubMed ID: 34148403
    [No Abstract]   [Full Text] [Related]  

  • 12. Electron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells for MRI cell labeling studies.
    Danhier P; De Preter G; Boutry S; Mahieu I; Leveque P; Magat J; Haufroid V; Sonveaux P; Bouzin C; Feron O; Muller RN; Jordan BF; Gallez B
    Contrast Media Mol Imaging; 2012; 7(3):302-7. PubMed ID: 22539400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatially resolved biologic information from in vivo EPRI, OMRI, and MRI.
    Matsumoto K; Subramanian S; Murugesan R; Mitchell JB; Krishna MC
    Antioxid Redox Signal; 2007 Aug; 9(8):1125-41. PubMed ID: 17571957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of nitroxides for assessing perfusion, oxygenation, and viability of tissues: in vivo EPR and MRI studies.
    Gallez B; Bacic G; Goda F; Jiang J; O'Hara JA; Dunn JF; Swartz HM
    Magn Reson Med; 1996 Jan; 35(1):97-106. PubMed ID: 8771027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal Functional Imaging for Cancer/Tumor Microenvironments Based on MRI, EPRI, and PET.
    Matsumoto KI; Mitchell JB; Krishna MC
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo EPR: when, how and why?
    Gallez B; Swartz HM
    NMR Biomed; 2004 Aug; 17(5):223-5. PubMed ID: 15366024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring Combretastatin A4-induced tumor hypoxia and hemodynamic changes using endogenous MR contrast and DCE-MRI.
    Colliez F; Fruytier AC; Magat J; Neveu MA; Cani PD; Gallez B; Jordan BF
    Magn Reson Med; 2016 Feb; 75(2):866-72. PubMed ID: 25765253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron Paramagnetic Resonance Spectroscopy of Metalloproteins.
    Jasniewski A; Hu Y; Ribbe MW
    Methods Mol Biol; 2019; 1876():197-211. PubMed ID: 30317483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes.
    Hu F; Zhao YS
    Nanoscale; 2012 Oct; 4(20):6235-43. PubMed ID: 22971876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.